Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Assets Average (2016 - 2025)

Integra Lifesciences Holdings' Assets Average history spans 15 years, with the latest figure at $3.6 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 10.55% year-over-year to $3.6 billion; the TTM value through Dec 2025 reached $3.6 billion, down 10.55%, while the annual FY2025 figure was $3.8 billion, 2.3% down from the prior year.
  • Assets Average for Q4 2025 was $3.6 billion at Integra Lifesciences Holdings, down from $3.7 billion in the prior quarter.
  • Across five years, Assets Average topped out at $4.1 billion in Q2 2024 and bottomed at $3.6 billion in Q4 2025.
  • The 4-year median for Assets Average is $3.8 billion (2022), against an average of $3.9 billion.
  • The largest annual shift saw Assets Average increased 8.41% in 2024 before it dropped 10.55% in 2025.
  • A 4-year view of Assets Average shows it stood at $3.8 billion in 2022, then decreased by 2.28% to $3.8 billion in 2023, then increased by 7.74% to $4.1 billion in 2024, then fell by 10.55% to $3.6 billion in 2025.
  • Per Business Quant, the three most recent readings for IART's Assets Average are $3.6 billion (Q4 2025), $3.7 billion (Q3 2025), and $3.9 billion (Q2 2025).